Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 7 » default
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (468)
- Volume 10, 2023 (120)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Archive: Volume 7, 2020
Effect of Inhibiting Tumor Angiogenesis After Embolization in the Treatment of HCC with Apatinib-Loaded p(N-Isopropyl-Acrylamide-co-Butyl Methyl Acrylate) Temperature-Sensitive Nanogel
Zhou C, Shi Q, Liu J, Huang S, Yang C, Xiong B
Journal of Hepatocellular Carcinoma 2020, 7:447-456
Published Date: 31 December 2020
Efficacy of Local Treatments for Hepatocellular Carcinoma Involving the Inferior Vena Cava and/or Right Atrium
Lee HA, Rim CH
Journal of Hepatocellular Carcinoma 2020, 7:435-446
Published Date: 21 December 2020
Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion
Kulik L, da Fonseca LG, He AR, Rimola J, Wilson Woods A, Zöllner YF, Galle PR
Journal of Hepatocellular Carcinoma 2020, 7:423-433
Published Date: 21 December 2020
Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma
Zong J, Fan Z, Zhang Y
Journal of Hepatocellular Carcinoma 2020, 7:413-422
Published Date: 18 December 2020
Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, Seong J, Won JY, Han DH, Kim BK
Journal of Hepatocellular Carcinoma 2020, 7:403-412
Published Date: 17 December 2020
Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant
Teng CF, Li TC, Wang T, Wu TH, Wang J, Wu HC, Shyu WC, Su IJ, Jeng LB
Journal of Hepatocellular Carcinoma 2020, 7:385-401
Published Date: 17 December 2020
Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?
Sun X, Hu D, Zhang Y, Lyu N, Xu L, Chen Q, Lai J, Chen M, Zhao M
Journal of Hepatocellular Carcinoma 2020, 7:377-384
Published Date: 16 December 2020
Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma
Li M, Hu J, Jin R, Cheng H, Chen H, Li L, Guo K
Journal of Hepatocellular Carcinoma 2020, 7:361-376
Published Date: 8 December 2020
Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC
Gao X, Zhan M, Wang L, Ding Y, Niu J
Journal of Hepatocellular Carcinoma 2020, 7:347-360
Published Date: 1 December 2020
Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy
Sun X, Hu D, Yang Z, Liu Z, Wang J, Chen J, Xu L, Zhou Z, Chen M, Zhang Y
Journal of Hepatocellular Carcinoma 2020, 7:337-345
Published Date: 1 December 2020
Value of Follow-Up Chest Computed Tomography in the Surveillance of Patients with Hepatocellular Carcinoma
Moawad AW, Elsayes KM, Benamar F, Rao K, Sun J, Szklaruk J
Journal of Hepatocellular Carcinoma 2020, 7:331-335
Published Date: 18 November 2020
Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma
Hu B, Yang XB, Sang XT
Journal of Hepatocellular Carcinoma 2020, 7:315-330
Published Date: 11 November 2020
Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients
Jensen C, Holm Nielsen S, Eslam M, Genovese F, Nielsen MJ, Vongsuvanh R, Uchila R, van der Poorten D, George J, Karsdal MA, Leeming DJ, Willumsen N
Journal of Hepatocellular Carcinoma 2020, 7:301-313
Published Date: 9 November 2020
Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors
Chen S, Huang Z, Jia W, Tao H, Zhang S, Ma J, Liu Z, Wang J, Wang L, Cui P, Zhang Z, Huang D, Wu Z, Zheng X, Hu Y
Journal of Hepatocellular Carcinoma 2020, 7:289-299
Published Date: 2 November 2020
Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
Yu Q, Wu L, Ji J, Feng J, Dai W, Li J, Wu J, Guo C
Journal of Hepatocellular Carcinoma 2020, 7:271-288
Published Date: 29 October 2020
miR-3 Encoded by Hepatitis B Virus Downregulates PTEN Protein Expression and Promotes Cell Proliferation
Tang J, Xiao XQ, Jiang Y, Tian Y, Peng Z, Yang M, Xu Z, Gong G
Journal of Hepatocellular Carcinoma 2020, 7:257-269
Published Date: 29 October 2020
Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management
Xu W, Liu F, Shen X, Li R
Journal of Hepatocellular Carcinoma 2020, 7:233-256
Published Date: 27 October 2020
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients
Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, Zhan M, Wang B, Peng F, Gao X, Shi Y, Wen X, Ji Y, Jin Q, Niu J
Journal of Hepatocellular Carcinoma 2020, 7:219-232
Published Date: 23 October 2020
Assessing the Survival Benefit of Surgery and Various Types of Radiation Therapy for Treatment of Hepatocellular Carcinoma: Evidence from the Surveillance, Epidemiology, and End Results Registries
Shi F, Wang C, Kong Y, Yang L, Li J, Zhu G, Guo J, Zheng Q, Zhang B, Wang S
Journal of Hepatocellular Carcinoma 2020, 7:201-218
Published Date: 19 October 2020
Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study
Lu L, Zhang Y, Zheng P, Wu Z, Wang X, Chen Y, Chen X
Journal of Hepatocellular Carcinoma 2020, 7:191-199
Published Date: 15 October 2020
Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
Kobayashi S, Tajiri K, Murayama A, Entani T, Futsukaichi Y, Nagata K, Takahashi K, Yasuda I
Journal of Hepatocellular Carcinoma 2020, 7:181-189
Published Date: 14 October 2020
The Clinicopathological and Imaging Characteristics of Primary Hepatic Carcinosarcoma and a Review of the Literature
Bin F, Chen Z, Liu P, Liu J, Mao Z
Journal of Hepatocellular Carcinoma 2020, 7:169-180
Published Date: 13 October 2020
Amide Proton Transfer Imaging vs Diffusion Kurtosis Imaging for Predicting Histological Grade of Hepatocellular Carcinoma
Wu B, Jia F, Li X, Zhang M, Han D, Jia Z
Journal of Hepatocellular Carcinoma 2020, 7:159-168
Published Date: 9 October 2020
Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization
Tran Cao H, Tzeng CW, Chun YS, Aloia T, Vauthey JN
Journal of Hepatocellular Carcinoma 2020, 7:155-158
Published Date: 28 September 2020
Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO
Journal of Hepatocellular Carcinoma 2020, 7:143-153
Published Date: 16 September 2020
Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
Raybould AL, Sanoff H
Journal of Hepatocellular Carcinoma 2020, 7:133-142
Published Date: 15 September 2020
Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC
Journal of Hepatocellular Carcinoma 2020, 7:117-131
Published Date: 14 September 2020
Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
Campani C, Bensi C, Milani S, Galli A, Tarocchi M
Journal of Hepatocellular Carcinoma 2020, 7:107-116
Published Date: 30 July 2020
Inflammation-Based Prognostic Scores in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Transplantation
Ren A, Li Z, Zhang X, Deng R, Ma Y
Journal of Hepatocellular Carcinoma 2020, 7:101-106
Published Date: 7 July 2020
Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations
Debaillon Vesque A, Decraecker M, Blanc JF
Journal of Hepatocellular Carcinoma 2020, 7:91-99
Published Date: 9 June 2020
Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging
Moawad AW, Szklaruk J, Lall C, Blair KJ, Kaseb AO, Kamath A, Rohren SA, Elsayes KM
Journal of Hepatocellular Carcinoma 2020, 7:77-89
Published Date: 23 April 2020
Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
Dash S, Aydin Y, Widmer KE, Nayak L
Journal of Hepatocellular Carcinoma 2020, 7:45-76
Published Date: 15 April 2020
Rare Site Hepatocellular Carcinoma Metastasis
Boldo E, Santafe A, Mayol A, Lozoya R, Coret A, Escribano D, Fortea-Sanchis C, Muñoz A, Pastor JC, Perez de Lucia G, Bosch N
Journal of Hepatocellular Carcinoma 2020, 7:39-44
Published Date: 25 March 2020
Impact of Next-Generation Sequencing on Outcomes in Hepatocellular Carcinoma: How Precise Are We Really?
Dominguez DA, Wang XW
Journal of Hepatocellular Carcinoma 2020, 7:33-37
Published Date: 19 March 2020
Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
Liu T, Li S, Wu L, Yu Q, Li J, Feng J, Zhang J, Chen J, Zhou Y, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C
Journal of Hepatocellular Carcinoma 2020, 7:19-31
Published Date: 18 February 2020
The Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma
Singh P, Toom S, Avula A, Kumar V, Rahma OE
Journal of Hepatocellular Carcinoma 2020, 7:11-17
Published Date: 10 February 2020
Exploring Metabolic Consequences of CPS1 and CAD Dysregulation in Hepatocellular Carcinoma by Network Reconstruction
Dumenci OE, U AMR, Khan SA, Holmes E, Taylor-Robinson SD
Journal of Hepatocellular Carcinoma 2020, 7:1-9
Published Date: 7 January 2020